Information:
Fel:
ID
14364
Beskrivning
Zileuton CR vs Placebo in Poorly Controlled Asthma Patients on Moderate Dose ICS; ODM derived from: https://clinicaltrials.gov/show/NCT00486343
Länk
https://clinicaltrials.gov/show/NCT00486343
Nyckelord
Versioner (1)
- 2016-04-12 2016-04-12 -
Rättsinnehavare
CC BY-NC 3.0
Uppladdad den
12 april 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Asthma NCT00486343
Eligibility Asthma NCT00486343
- StudyEvent: Eligibility
Similar models
Eligibility Asthma NCT00486343
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
age
Item
1. male or female 12-70 years of age (inclusive).
boolean
C0001779 (UMLS CUI [1])
asthma
Item
2. diagnosis of asthma for at least 6 months.
boolean
C0004096 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
morning fev1
Item
3. morning fev1 of 40-80% normal.
boolean
C0748133 (UMLS CUI [1,1])
C0332170 (UMLS CUI [1,2])
C0332170 (UMLS CUI [1,2])
reversible airflow restriction
Item
4. demonstrated reversible airflow restriction.
boolean
C1527303 (UMLS CUI [1,1])
C0205343 (UMLS CUI [1,2])
C0205343 (UMLS CUI [1,2])
non-smoker
Item
5. non-smokers.
boolean
C0337672 (UMLS CUI [1])
ics
Item
6. on moderate doses of ics with inadequate asthma control.
boolean
C3248292 (UMLS CUI [1])
signed icf
Item
7. signed icf
boolean
C0021430 (UMLS CUI [1])
copd
Item
1. diagnosis of copd.
boolean
C0024117 (UMLS CUI [1])
uncontrolled systemic illness
Item
2. uncontrolled systemic illness.
boolean
C0009488 (UMLS CUI [1])
hypersensitivity to any component of zyflo cr
Item
3. hypersensitivity to any component of zyflo cr
boolean
C0020517 (UMLS CUI [1,1])
C1951657 (UMLS CUI [1,2])
C1951657 (UMLS CUI [1,2])
asthma exacerbation with an unscheduled visit to an er or hospital
Item
4. any patient with an unscheduled visit to an er or hospital for asthma exacerbation within past 3 months.
boolean
C0349790 (UMLS CUI [1])
C0040223 (UMLS CUI [2])
C0583237 (UMLS CUI [3])
C0019993 (UMLS CUI [4])
C0040223 (UMLS CUI [2])
C0583237 (UMLS CUI [3])
C0019993 (UMLS CUI [4])
hepatitis or acute liver disease
Item
5. history of hepatitis or active liver disease.
boolean
C0019158 (UMLS CUI [1])
C0023895 (UMLS CUI [2])
C0023895 (UMLS CUI [2])
ALT
Item
6. alt greater than 3xuln.
boolean
C0201836 (UMLS CUI [1])
HIV
Item
7. history of hiv infection
boolean
C0019682 (UMLS CUI [1])
history of drug or alcohol abuse
Item
8. recent history of drug or alcohol abuse.
boolean
C0038586 (UMLS CUI [1])
oral corticosteroids within one month, cromolyn sodium or nedocromil within 14 days, theophylline, laba, zyflo, or leukotriene modifiers, warfarin or propranolol, inhaled anti-cholinergics, or combination laba/ics
Item
9. oral corticosteroids within one month, cromolyn sodium or nedocromil within 14 days, theophylline, laba, zyflo, or leukotriene modifiers, warfarin or propranolol, inhaled anti-cholinergics, or combination laba/ics.
boolean
C0001617 (UMLS CUI [1])
C0012694 (UMLS CUI [2])
C0068483 (UMLS CUI [3])
C0039771 (UMLS CUI [4])
C2936789 (UMLS CUI [5])
C0595726 (UMLS CUI [6])
C0724508 (UMLS CUI [7])
C0043031 (UMLS CUI [8])
C0033497 (UMLS CUI [9])
C0354764 (UMLS CUI [10])
C0012694 (UMLS CUI [2])
C0068483 (UMLS CUI [3])
C0039771 (UMLS CUI [4])
C2936789 (UMLS CUI [5])
C0595726 (UMLS CUI [6])
C0724508 (UMLS CUI [7])
C0043031 (UMLS CUI [8])
C0033497 (UMLS CUI [9])
C0354764 (UMLS CUI [10])
omalizumab
Item
10. omalizumab within 3 months.
boolean
C0966225 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C1514463 (UMLS CUI [1,2])
pregnancy
Item
11. pregnant female.
boolean
C0032961 (UMLS CUI [1])
participation with 30 days in investigational study
Item
12. participation with 30 days in investigational study.
boolean
C2348568 (UMLS CUI [1])